Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

123-03-5

Cetylpiridinium chloride

123-03-5
154-93-8

Carmustine

154-93-8
305-03-3

Chlorambucil

305-03-3
123318-82-1

Clofarabine

123318-82-1
479-13-0

Coumestrol

479-13-0
67-48-1

Choline chloride

67-48-1
85721-33-1

Ciprofloxacin

85721-33-1
147-94-4

Cytarabine

147-94-4
84957-30-2

Cefquinome

84957-30-2
118443-89-3

Cefquinome sulfate

118443-89-3
27164-46-1

Cefazolin sodium salt

27164-46-1
3697-42-5

Chlorhexidine 2HCl

3697-42-5
57-88-5

Cholesterol

57-88-5
7778-44-1

Calcium arsenate

7778-44-1
38339-11-6

Clenproperol

38339-11-6
104010-37-9

Ceftiofur Sodium

104010-37-9
54239-39-3

Cimbuterol

54239-39-3
2971-90-6

Clopidol

2971-90-6
5326-23-8

6-Chloronicotinic acid

5326-23-8
528-48-3

Fisetin

528-48-3